SINGULAIR - Request More Information

Commited to bringing out the best in medicine

Healthcare Professionals

About SINGULAIR^TM†

SINGULAIR for Asthma

	Leukotrienes in Asthma
	SINGULAIR vs.ICS Alone
	SINGULAIR With ICS vs. ICS Alone
	SINGULAIR With ICS vs. LABA With ICS
	Patient Satisfaction

SINGULAIR for Asthma with Allergic Rhinitis

	Leukotrienes in Asthma with Allergic Rhinitis
	Allergic Rhinitis Can Make Asthma Worse
	Symptom Relief & Control

SINGULAIR for Asthma in Kids

	Asthma Control in Kids
	Symptom Relief in Kids 2 to 5 Years Old
	Symptom Relief in Kids 6 to 14 Years Old
	Simplify Asthma Management

Dosing and Safety Profile

Resources

Prescribing Information

	4mg + 5mg chewable tablet + 10 mg film-coated tablet
	4 mg granules
	paediatric 4 mg granules

Key Publications

Slide Sets

MetaForum

	Agenda
	Scientific Overview

Conferences

Useful Links



					Email Updates
					Request More Information

This website was designed to provide key relevant information on SINGULAIR^TM. However, if you still have questions or would like additional information, please complete the form below with your specific request. An * indicates a required field.

Please contact MSD at:
Merck Sharp & Dohme, IDEA A.G - Gulf
Al Khazna Tower, 16th Flr. - Najda St.
P.O. Box 29034
Tel: +971-2-699 8600
Fax: +971-2-672 5312









First Name *

Family Name *

Address 1 *

Address 2

City *

Telephone *

Email Address: *

* * indicates a required field

	PRIVACY POLICY

	Please read our Privacy Policy to learn how your information is protected. View Privacy Policy

Before prescribing, please consult the full product circular.
† Trademark of Merck & Co., Inc., Whitehouse Station, NJ, USA